Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)

China flag China · Delayed Price · Currency is CNY
39.29
-0.50 (-1.26%)
Apr 28, 2026, 3:00 PM CST
-40.56%
Market Cap 49.68B
Revenue (ttm) 1.94B
Net Income (ttm) -388.47M
Shares Out 1.26B
EPS (ttm) -0.30
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,143,164
Average Volume 3,181,003
Open 38.50
Previous Close 39.79
Day's Range 38.27 - 39.59
52-Week Range 37.85 - 80.00
Beta 0.93
RSI 48.31
Earnings Date Apr 21, 2026

About SHA:603392

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. research, develops, produces, and sells biological diagnostic tests and vaccines in China and internationally. The company offers in vitro diagnostics and automated laboratory instruments, including Wan600, Wan BC2800, WanTLA immunoassay and biochemistry analyzers; chemiluminescence and biochemistry tests, including novel diagnostic tests for detection of Hepatitis virus infections; P-85 Ab for nasopharyngeal cancer screening; and TB-IGRA for large population screening. It also provides di... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1991
Employees 3,790
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603392
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.